271 related articles for article (PubMed ID: 26341780)
1. Stem cells in genetically-engineered mouse models of prostate cancer.
Shibata M; Shen MM
Endocr Relat Cancer; 2015 Dec; 22(6):T199-208. PubMed ID: 26341780
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.
Deng Q; Tang DG
Endocr Relat Cancer; 2015 Dec; 22(6):T209-20. PubMed ID: 26285606
[TBL] [Abstract][Full Text] [Related]
3. The many ways to make a luminal cell and a prostate cancer cell.
Strand DW; Goldstein AS
Endocr Relat Cancer; 2015 Dec; 22(6):T187-97. PubMed ID: 26307022
[TBL] [Abstract][Full Text] [Related]
4. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
[TBL] [Abstract][Full Text] [Related]
6. Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.
Sun Y; Wang BE; Leong KG; Yue P; Li L; Jhunjhunwala S; Chen D; Seo K; Modrusan Z; Gao WQ; Settleman J; Johnson L
Cancer Res; 2012 Jan; 72(2):527-36. PubMed ID: 22108827
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis.
Yan J; De Melo J; Cutz JC; Aziz T; Tang D
Br J Cancer; 2014 May; 110(10):2593-603. PubMed ID: 24762960
[TBL] [Abstract][Full Text] [Related]
8. Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line.
Watson PA; Ellwood-Yen K; King JC; Wongvipat J; Lebeau MM; Sawyers CL
Cancer Res; 2005 Dec; 65(24):11565-71. PubMed ID: 16357166
[TBL] [Abstract][Full Text] [Related]
9. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
[TBL] [Abstract][Full Text] [Related]
10. [Prostate cancer and apoptosis].
Mayora A; Arvelo F
Invest Clin; 2011 Dec; 52(4):376-96. PubMed ID: 22523847
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells.
Huss WJ; Gray DR; Greenberg NM; Mohler JL; Smith GJ
Cancer Res; 2005 Aug; 65(15):6640-50. PubMed ID: 16061644
[TBL] [Abstract][Full Text] [Related]
12. IGFBP-3 is a metastasis suppression gene in prostate cancer.
Mehta HH; Gao Q; Galet C; Paharkova V; Wan J; Said J; Sohn JJ; Lawson G; Cohen P; Cobb LJ; Lee KW
Cancer Res; 2011 Aug; 71(15):5154-63. PubMed ID: 21697285
[TBL] [Abstract][Full Text] [Related]
13. Identification of Different Classes of Luminal Progenitor Cells within Prostate Tumors.
Agarwal S; Hynes PG; Tillman HS; Lake R; Abou-Kheir WG; Fang L; Casey OM; Ameri AH; Martin PL; Yin JJ; Iaquinta PJ; Karthaus WR; Clevers HC; Sawyers CL; Kelly K
Cell Rep; 2015 Dec; 13(10):2147-58. PubMed ID: 26628377
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the concept of cancer stem cells in prostate cancer.
Wang ZA; Shen MM
Oncogene; 2011 Mar; 30(11):1261-71. PubMed ID: 21119602
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
Cox ME; Deeble PD; Lakhani S; Parsons SJ
Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
[TBL] [Abstract][Full Text] [Related]
16. A luminal epithelial stem cell that is a cell of origin for prostate cancer.
Wang X; Kruithof-de Julio M; Economides KD; Walker D; Yu H; Halili MV; Hu YP; Price SM; Abate-Shen C; Shen MM
Nature; 2009 Sep; 461(7263):495-500. PubMed ID: 19741607
[TBL] [Abstract][Full Text] [Related]
17. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
[TBL] [Abstract][Full Text] [Related]
18. Advances in mouse models of prostate cancer.
Ahmad I; Sansom OJ; Leung HY
Expert Rev Mol Med; 2008 Jun; 10():e16. PubMed ID: 18538039
[TBL] [Abstract][Full Text] [Related]
19. Emergence of androgen independence at early stages of prostate cancer progression in Nkx3.1; Pten mice.
Gao H; Ouyang X; Banach-Petrosky WA; Shen MM; Abate-Shen C
Cancer Res; 2006 Aug; 66(16):7929-33. PubMed ID: 16912166
[TBL] [Abstract][Full Text] [Related]
20. Androgen deprivation and stem cell markers in prostate cancers.
Tang Y; Hamburger AW; Wang L; Khan MA; Hussain A
Int J Clin Exp Pathol; 2009 Nov; 3(2):128-38. PubMed ID: 20126580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]